157 related articles for article (PubMed ID: 25880253)
1. Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report.
Tazzari M; Palassini E; Vergani B; Villa A; Rini F; Negri T; Colombo C; Crippa F; Morosi C; Casali PG; Pilotti S; Stacchiotti S; Rivoltini L; Castelli C
BMC Cancer; 2015 Feb; 15():58. PubMed ID: 25880253
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
[TBL] [Abstract][Full Text] [Related]
3. Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.
Moritake H; Sugimoto T; Asada Y; Yoshida MA; Maehara Y; Epstein AL; Kuroda H
Cancer Genet Cytogenet; 2002 May; 135(1):48-56. PubMed ID: 12072203
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
Outani H; Tanaka T; Wakamatsu T; Imura Y; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
BMC Cancer; 2014 Jun; 14():455. PubMed ID: 24946937
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
Coindre JM; Hostein I; Terrier P; Bouvier-Labit C; Collin F; Michels JJ; Trassard M; Marques B; Ranchere D; Guillou L
Cancer; 2006 Sep; 107(5):1055-64. PubMed ID: 16878328
[TBL] [Abstract][Full Text] [Related]
6. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
[TBL] [Abstract][Full Text] [Related]
7. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
Li KK; Goodall J; Goding CR; Liao SK; Wang CH; Lin YC; Hiraga H; Nojima T; Nagashima K; Schaefer KL; Lee KA
Br J Cancer; 2003 Sep; 89(6):1072-8. PubMed ID: 12966428
[TBL] [Abstract][Full Text] [Related]
8. Association of the t(12;22)(q13;q12) EWS/ATF1 rearrangement with polyphenotypic round cell sarcoma of bone: a case report.
Somers GR; Viero S; Nathan PC; Teshima I; Pereira C; Zielenska M
Am J Surg Pathol; 2005 Dec; 29(12):1673-9. PubMed ID: 16327442
[TBL] [Abstract][Full Text] [Related]
9. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
Antonescu CR; Nafa K; Segal NH; Dal Cin P; Ladanyi M
Clin Cancer Res; 2006 Sep; 12(18):5356-62. PubMed ID: 17000668
[TBL] [Abstract][Full Text] [Related]
10. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
Covinsky M; Gong S; Rajaram V; Perry A; Pfeifer J
Hum Pathol; 2005 Jan; 36(1):74-81. PubMed ID: 15712185
[TBL] [Abstract][Full Text] [Related]
11. Primary Clear Cell Sarcoma of the Ileum: A Case Report With Next-Generation Sequencing Analysis.
Zhu P; Zhang T; Bi K; Wu Y; Chen X; Zhang H; Huang D; Zhang L; Zeng Y; Yi X
Int J Surg Pathol; 2021 Sep; 29(6):677-684. PubMed ID: 33412984
[TBL] [Abstract][Full Text] [Related]
12. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
[TBL] [Abstract][Full Text] [Related]
13. New type of chimeric fusion product between the EWS and ATFI genes in clear cell sarcoma (malignant melanoma of soft parts).
Pellín A; Monteagudo C; López-Ginés C; Carda C; Boix J; Llombart-Bosch A
Genes Chromosomes Cancer; 1998 Dec; 23(4):358-60. PubMed ID: 9824209
[TBL] [Abstract][Full Text] [Related]
14. Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4.
Klein O; Ebert LM; Nicholaou T; Browning J; Russell SE; Zuber M; Jackson HM; Dimopoulos N; Tan BS; Hoos A; Luescher IF; Davis ID; Chen W; Cebon J
Clin Cancer Res; 2009 Apr; 15(7):2507-13. PubMed ID: 19318477
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network.
Smrke A; Frezza AM; Giani C; Somaiah N; Brahmi M; Czarnecka AM; Rutkowski P; Van der Graaf W; Baldi GG; Connolly E; Duffaud F; Huang PH; Gelderblom H; Bhadri V; Grimison P; Mahar A; Stacchiotti S; Jones RL
ESMO Open; 2022 Jun; 7(3):100522. PubMed ID: 35717681
[TBL] [Abstract][Full Text] [Related]
17. EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.
Yamada K; Ohno T; Aoki H; Semi K; Watanabe A; Moritake H; Shiozawa S; Kunisada T; Kobayashi Y; Toguchida J; Shimizu K; Hara A; Yamada Y
J Clin Invest; 2013 Feb; 123(2):600-10. PubMed ID: 23281395
[TBL] [Abstract][Full Text] [Related]
18. Tumor response to sunitinib malate observed in clear-cell sarcoma.
Stacchiotti S; Grosso F; Negri T; Palassini E; Morosi C; Pilotti S; Gronchi A; Casali PG
Ann Oncol; 2010 May; 21(5):1130-1. PubMed ID: 20093352
[No Abstract] [Full Text] [Related]
19. Primary clear cell sarcoma of the femur: a unique case with RT-PCR and direct sequencing confirmation of EWSR1/ATF1 fusion gene.
Kubota Y; Tanaka K; Hisaoka M; Daa T; Iwasaki T; Kawano M; Itonaga I; Tsumura H
BMC Musculoskelet Disord; 2021 Jan; 22(1):99. PubMed ID: 33478436
[TBL] [Abstract][Full Text] [Related]
20. Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma.
Weber J; Boswell W; Smith J; Hersh E; Snively J; Diaz M; Miles S; Liu X; Obrocea M; Qiu Z; Bot A
J Immunother; 2008; 31(2):215-23. PubMed ID: 18481391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
